Answers are grounded in this paper and cite their sources.
Chemotherapy and radiation therapy which are standard methods of treatment for various cancers often result in suppression of hematopoiesis accompanied by reduction in the number of hematopoietic stem cells and their progeny. We investigated a clinically potential use of Phellinus Linteus Polysaccharide (PLP) in the treatment of various cytopenias induced by radiotherapy. The mice were given Phellinus linteus polysaccharide orally 100 mg/kg once a day for twenty consecutive days either before (pre-treatment) or after gamma-irradiation (therapy). Mice that received pre-treatment were less sensitive to irradiation. Ten days after irradiation, the number of Red Blood Cells (RBC), White Blood Cells (WBC) and platelets decreased, but the number in PLP pre-treated group was higher than control. Twenty days after irradiation, all blood cells increased significan tly compared to control (P<0.05). The number of bone marrow cells and spleen in mice treated with PLP had significantly increased after radiation compared to control (P<0.05). But there was no significant difference between the number of bone marrow cells and spleen in mice of III and IV groups treated with PLP,and blank control (P>0.05). Our experimental results show that Phellinus Linteus Polysaccha ride (PLP) can accelerate restoration of radiation induced hemato poietic damage in bone marrow and spleen of mice. However, further research is necessary before implementation in human protection against ionizing radiation, especially in the treat ment of cancer patients exposed to chemotherapy and radiotherapy.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: